Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholangiocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02184871
What this trial is testing

Next Generation Sequencing in Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
University of Bologna 45
Large-scale testing (Phase 3)Ended earlyNCT02807181
What this trial is testing

SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Sirtex Medical 89
Testing effectiveness (Phase 2)Study completedNCT03111732
What this trial is testing

Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)

Who this might be right for
Biliary Tract NeoplasmsCholangiocarcinomaBile Duct Cancer+2 more
National Cancer Institute (NCI) 11
Not applicableWithdrawnNCT03563352
What this trial is testing

Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer

Who this might be right for
Breast CarcinomaCholangiocarcinomaColorectal Carcinoma+4 more
University of Southern California
Not applicableActive Not RecruitingNCT06707025
What this trial is testing

The Expression of CD24 "do-not-eat-me" Signal in Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Hadassah Medical Organization 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT06999512
What this trial is testing

Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for Cancer

Who this might be right for
Hepatobiliary CancerPancreatic Cancer
Assistance Publique - Hôpitaux de Paris 526
Not applicableLooking for participantsNCT07291063
What this trial is testing

Anti-PD-1/PD-L1 Antibodies Plus Gemcitabine and Cisplatin for Advanced CCA

Who this might be right for
Cholangiocarcinoma
Shanghai Zhongshan Hospital 50
Testing effectiveness (Phase 2)UnknownNCT01798147
What this trial is testing

Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Cholangiocellular Carcinoma (CCC).

Who this might be right for
Intrahepatic Cholangiocellular Carcinoma
Johannes Gutenberg University Mainz 24
Testing effectiveness (Phase 2)Looking for participantsNCT07105748
What this trial is testing

HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA)

Who this might be right for
Mixed Hepatocellular-cholangiocarcinoma
Fudan University 45
Not applicableLooking for participantsNCT07206355
What this trial is testing

In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers

Who this might be right for
Biliary Tract Cancer (BTC)Biliary Tract Cancer (CCA)Cholangiocarcinoma+4 more
University of Nottingham 160
Testing effectiveness (Phase 2)Study completedNCT04301778
What this trial is testing

Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma

Who this might be right for
Unresectable Intrahepatic Cholangiocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 5
Not applicableLooking for participantsNCT06260943
What this trial is testing

Targeted Navigation in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinomaHepatobiliary Cancer
University of Miami 210
Not applicableLooking for participantsNCT07263217
What this trial is testing

Mechanistic Study on the Protective and Regenerative Effects of Spirulina in Hepatectomy-Related Liver Injury

Who this might be right for
Cholangiocarcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 30
Testing effectiveness (Phase 2)Looking for participantsNCT05265208
What this trial is testing

Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer

Who this might be right for
Resectable Intrahepatic Cholangiocarcinoma
Center Eugene Marquis 62
Not applicableNot Yet RecruitingNCT07768085
What this trial is testing

Pragmatic RCT of AI-Assisted Reading for Malignant Hepatic Lesions on CE-CT

Who this might be right for
Hepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (Icc)Hepatic Metastasis+3 more
Shengjing Hospital 40,000
Testing effectiveness (Phase 2)WithdrawnNCT00713687
What this trial is testing

Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Technical University of Munich
Early research (Phase 1)UnknownNCT06256055
What this trial is testing

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

Who this might be right for
Malignant MesotheliomaColorectal CancerBile Duct Cancer+4 more
UTC Therapeutics Inc. 24
Not applicableStudy completedNCT05874934
What this trial is testing

Endoscopic Drainage of Presumed Resectable pCCA Using an Intrahepatic Plastic Stent With Retrieval String

Who this might be right for
Perihilar Cholangiocarcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 40
Testing effectiveness (Phase 2)UnknownNCT03943043
What this trial is testing

Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer

Who this might be right for
Cholangiocarcinoma
Istituto Clinico Humanitas 85
Not applicableWithdrawnNCT01875549
What this trial is testing

Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent

Who this might be right for
Obstruction of Biliary TreeCholangiocarcinomaHepatocellular Carcinoma+2 more
Kwang Hyuck Lee
Next Page